Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
January 30, 2019updated 15 Dec 2021 10:24am

US releases updated seasonal flu guidance after almost a decade

The Infectious Diseases Society of America (IDSA) recently re-issued the clinical practice guidelines for seasonal influenza, last updated in 2009.

By GlobalData Healthcare

The Infectious Diseases Society of America (IDSA) recently re-issued the clinical practice guidelines for seasonal influenza, last updated in 2009. The latest publication addresses updates in diagnosis, treatment, prevention and outbreak management of seasonal influenza, commonly known as the flu.

In the US, GlobalData epidemiologists forecast the number of diagnosed incident cases of seasonal influenza by source of diagnosis in 2018; approximately 87% of cases were diagnosed as outpatients, 9% were lab-confirmed, and 3% were inpatients (as shown in Figure 1). GlobalData epidemiologists believe that these new guidelines will likely affect the number of diagnosed incident cases of seasonal flu in the US, as well as change the distribution of cases by source of diagnosis.

Key changes to the guidelines include recommendations for diagnostic testing and high-risk populations. The new guidelines advise clinicians to use rapid molecular assays over rapid influenza diagnostic tests (RIDTs) in outpatients; this will improve both flu detection and diagnosis, as RIDTs often produce false-negative results.

Figure 1: US, Diagnosed Incident Cases of Seasonal Influenza by Source of Diagnosis, Both Sexes, All Ages, N, 2018

Seasonal flu guidance

Source: GlobalData. © GlobalData

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
The powerful networks advancing life sciences in Charleston | USA
The power of infrastructure: How Charleston | SC | USA is expanding horizons for life science companies

Additionally, the guidelines incorporate the approval of new antiviral drugs that can reduce the severity and duration of seasonal flu. IDSA recommends prompt administration of antiviral treatment in high-risk populations (immunocompromised, elderly, pregnant women, infants) to reduce influenza-related complications and thus hospitalization.

The impact of these new recommendations will likely be twofold: one, an increase in the number of diagnosed outpatients due to more accurate testing; and two, a decrease in flu-related hospitalizations due to early antiviral treatment in high-risk populations. GlobalData epidemiologists suggest further analysis of surveillance data over the next several flu seasons to more clearly assess and characterize the impact of these new guidelines.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU